New 3-Person IVF Technique Saves Kids From Genetic Diseases

Breakthrough in Mitochondrial Disease Prevention

A groundbreaking technique known as three-person in vitro fertilization (IVF) has helped eight children in the United Kingdom avoid devastating genetic diseases. This innovative approach, developed by scientists at Newcastle University, involves transferring genetic material from a mother’s fertilized egg into a healthy donor egg. The process aims to prevent the transmission of harmful mitochondrial DNA mutations that can lead to serious and often fatal conditions.

Mitochondria are the energy-producing structures within cells, and mutations in their DNA can affect multiple organs, especially those with high energy demands such as the brain, liver, heart, muscles, and kidneys. The new IVF method ensures that these mutated genes are not passed on to the child.

Healthy Start for Newborns

The eight children, who were born using this technique, have all shown good health at birth. Blood tests revealed no or very low levels of mitochondrial gene mutations. These children include one who is two years old, two between the ages of 1 and 2, and five infants. All of them have made normal developmental progress, according to the researchers.

Dr. Andy Greenfield, a reproductive medicine specialist at the University of Oxford, emphasized that the results represent decades of work involving scientific, technical, ethical, and regulatory challenges. He noted that the data collected through this research could open up new avenues for investigation and further advancements in the field.

How the Procedure Works

During standard IVF procedures, doctors can sometimes identify eggs with low-risk mitochondrial DNA mutations that are suitable for implantation. However, in cases where all the eggs carry mutations, the new technique comes into play. Here's how it works:

1. The mother’s egg is first fertilized with the father’s sperm.
2. The nuclei of the fertilized egg and the sperm, which contain the DNA instructions for the baby’s development, are removed.
3. These nuclei are then transferred into a donated fertilized egg that has had its own nuclei removed.
4. The donor egg, now containing the healthy mitochondria and the nuclear DNA from both parents, begins to divide and develop normally.

This process effectively replaces the faulty mitochondrial DNA with healthy DNA from the donor, significantly reducing the risk of inherited mitochondrial diseases.

Promising Results

In a second paper published in the same journal, the researchers reported that blood levels of mitochondrial DNA mutations were reduced by 95% to 100% in six newborns, and by 77% to 88% in two others, compared to the levels in their mothers. These findings indicate that the pronuclear transfer technique was effective in reducing the transmission of mitochondrial DNA disease.

The procedure was tested on 22 women whose babies were at risk of inheriting such genetic disorders. In addition to the eight women who delivered the children described in the report, another woman from the group is currently pregnant. Seven of the eight pregnancies were uneventful, while one woman experienced high lipid levels during her pregnancy. Importantly, there have been no miscarriages.

Ongoing Research and Development

The researchers have also explored other methods, such as transplanting the nucleus of a mother’s unfertilized egg into a donor egg before fertilizing it. However, they believe the current approach offers a more reliable way to prevent the transmission of genetic disorders.

In 2015, the United Kingdom became the first country to legalize research into mitochondrial donation treatment in humans. This marked a significant milestone in the fight against inherited mitochondrial diseases. In contrast, the United States has placed restrictions on similar procedures, with a congressional appropriations bill effectively banning pronuclear transfer for human use.

A New Era in Genetic Medicine

The success of this technique represents a major step forward in the field of genetic medicine. It not only offers hope to families affected by mitochondrial diseases but also highlights the importance of continued research, ethical considerations, and regulatory frameworks in advancing medical science. As this technology evolves, it may pave the way for even more effective treatments and interventions in the future.